|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-{4-[(dimethylamino)methyl]-2,5-dimethoxyphenyl}-2-methyl-1,2-dihydro-2,7-naphthyridin-1-one |
Database Links ![]() |
|
GtoPdb PubChem SID | 310264731 |
PubChem CID | 117072549 |
RCSB PDB Ligand | 5U6 |
Search Google for chemical match using the InChIKey | BJFSUDWKXGMUKA-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | BJFSUDWKXGMUKA |
Search UniChem for chemical match using the InChIKey | BJFSUDWKXGMUKA-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | BJFSUDWKXGMUKA |
SynPHARM | 83214 (in complex with bromodomain containing 9) |
Comments |
BI-9564 is an inhibitor of bromodomains in BRD7 and BRD9 [1-2]. BI-9564 is one of the compounds available from the Structural Genomics Consortium's epigenetic probes set. It was developed in collaboration with Boehringer Ingelheim. |